<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kwiecinski J</submitter><funding>British Heart Foundation</funding><funding>NHLBI NIH HHS</funding><funding>Medical Research Council</funding><funding>Chief Scientist Office</funding><funding>Wellcome Trust</funding><pagination>2000-2010</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6689460</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(10)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>This study aimed to assess the association between increased lesion peri-coronary adipose tissue (PCAT) density and coronary &lt;sup>18&lt;/sup>F-sodium fluoride (&lt;sup>18&lt;/sup>F-NaF) uptake on positron emission tomography (PET) in stable patients with high-risk coronary plaques (HRPs) shown on coronary computed tomography angiography (CTA).&lt;h4>Background&lt;/h4>Coronary &lt;sup>18&lt;/sup>F-NaF uptake reflects the rate of calcification of coronary atherosclerotic plaque. Increased PCAT density is associated with vascular inflammation. Currently, the relationship between increased PCAT density and &lt;sup>18&lt;/sup>F-NaF uptake in stable patients with HRPs on coronary CTA has not been characterized.&lt;h4>Methods&lt;/h4>Patients who underwent coronary CTA were screened for HRP, which was defined by 3 concurrent plaque features: positive remodeling; low attenuation plaque (LAP) (&lt;30 Hounsfield units [HU]) and spotty calcification; and obstructive coronary stenosis ≥50% (plaque volume >100 mm&lt;sup>3&lt;/sup>). Patients with HRPs were recruited to undergo &lt;sup>18&lt;/sup>F-NaF PET/CT. In lesions with stenosis ≥25%, quantitative plaque analysis, mean PCAT density, maximal coronary motion-corrected &lt;sup>18&lt;/sup>F-NaF standard uptake values (SUVmax), and target-to-background ratios (TBR) were measured.&lt;h4>Results&lt;/h4>Forty-one patients (age 65 ± 6 years; 68% men) were recruited. Fifty-one lesions in 23 patients (56%) showed increased coronary &lt;sup>18&lt;/sup>F-NaF activity. Lesions with &lt;sup>18&lt;/sup>F-NaF uptake had higher surrounding PCAT density than those without &lt;sup>18&lt;/sup>F-NaF uptake (-73 HU; interquartile range -79 to -68 HU vs. -86 HU; interquartile range -94 to -80 HU; p &lt; 0.001). &lt;sup>18&lt;/sup>F-NaF TBR and SUVmax were correlated with PCAT density (r = 0.63 and r = 0.68, respectively; all p &lt; 0.001). On adjusted multiple regression analysis, increased lesion PCAT density and LAP volume were associated with &lt;sup>18&lt;/sup>F-NaF TBR (β = 0.25; 95% confidence interval: 0.17 to 0.34; p &lt; 0.001 for PCAT, and β = 0.07; 95% confidence interval: 0.03 to 0.11; p = 0.002 for LAP).&lt;h4>Conclusions&lt;/h4>In patients with HRP features on coronary CTA, increased density of PCAT was associated with focal &lt;sup>18&lt;/sup>F-NaF PET uptake. Simultaneous assessment of these imaging biomarkers by &lt;sup>18&lt;/sup>F-NaF PET and CTA might refine cardiovascular risk prediction in stable patients with HRP features.</pubmed_abstract><journal>JACC. Cardiovascular imaging</journal><pubmed_title>Peri-Coronary Adipose Tissue Density Is Associated With &lt;sup>18&lt;/sup>F-Sodium Fluoride Coronary Uptake in Stable Patients With High-Risk Plaques.</pubmed_title><pmcid>PMC6689460</pmcid><funding_grant_id>CH/09/002</funding_grant_id><funding_grant_id>RG/16/10/32375</funding_grant_id><funding_grant_id>G0701127</funding_grant_id><funding_grant_id>RE/13/3/30183</funding_grant_id><funding_grant_id>WT103782AIA</funding_grant_id><funding_grant_id>FS/17/79/33226</funding_grant_id><funding_grant_id>FS/14/78/31020</funding_grant_id><funding_grant_id>R01 HL133616</funding_grant_id><funding_grant_id>PCL/17/04</funding_grant_id><funding_grant_id>R01 HL135557</funding_grant_id><pubmed_authors>Friedman JD</pubmed_authors><pubmed_authors>Kwiecinski J</pubmed_authors><pubmed_authors>Yun M</pubmed_authors><pubmed_authors>Doris MK</pubmed_authors><pubmed_authors>Lee SE</pubmed_authors><pubmed_authors>Jansen MA</pubmed_authors><pubmed_authors>Tamarappoo BK</pubmed_authors><pubmed_authors>Berman DS</pubmed_authors><pubmed_authors>Cadet S</pubmed_authors><pubmed_authors>Eisenberg E</pubmed_authors><pubmed_authors>Dey D</pubmed_authors><pubmed_authors>Otaki Y</pubmed_authors><pubmed_authors>Newby DE</pubmed_authors><pubmed_authors>Chang HJ</pubmed_authors><pubmed_authors>Dweck MR</pubmed_authors><pubmed_authors>Williams MC</pubmed_authors><pubmed_authors>Huynh PT</pubmed_authors><pubmed_authors>Slomka PJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Peri-Coronary Adipose Tissue Density Is Associated With &lt;sup>18&lt;/sup>F-Sodium Fluoride Coronary Uptake in Stable Patients With High-Risk Plaques.</name><description>&lt;h4>Objectives&lt;/h4>This study aimed to assess the association between increased lesion peri-coronary adipose tissue (PCAT) density and coronary &lt;sup>18&lt;/sup>F-sodium fluoride (&lt;sup>18&lt;/sup>F-NaF) uptake on positron emission tomography (PET) in stable patients with high-risk coronary plaques (HRPs) shown on coronary computed tomography angiography (CTA).&lt;h4>Background&lt;/h4>Coronary &lt;sup>18&lt;/sup>F-NaF uptake reflects the rate of calcification of coronary atherosclerotic plaque. Increased PCAT density is associated with vascular inflammation. Currently, the relationship between increased PCAT density and &lt;sup>18&lt;/sup>F-NaF uptake in stable patients with HRPs on coronary CTA has not been characterized.&lt;h4>Methods&lt;/h4>Patients who underwent coronary CTA were screened for HRP, which was defined by 3 concurrent plaque features: positive remodeling; low attenuation plaque (LAP) (&lt;30 Hounsfield units [HU]) and spotty calcification; and obstructive coronary stenosis ≥50% (plaque volume >100 mm&lt;sup>3&lt;/sup>). Patients with HRPs were recruited to undergo &lt;sup>18&lt;/sup>F-NaF PET/CT. In lesions with stenosis ≥25%, quantitative plaque analysis, mean PCAT density, maximal coronary motion-corrected &lt;sup>18&lt;/sup>F-NaF standard uptake values (SUVmax), and target-to-background ratios (TBR) were measured.&lt;h4>Results&lt;/h4>Forty-one patients (age 65 ± 6 years; 68% men) were recruited. Fifty-one lesions in 23 patients (56%) showed increased coronary &lt;sup>18&lt;/sup>F-NaF activity. Lesions with &lt;sup>18&lt;/sup>F-NaF uptake had higher surrounding PCAT density than those without &lt;sup>18&lt;/sup>F-NaF uptake (-73 HU; interquartile range -79 to -68 HU vs. -86 HU; interquartile range -94 to -80 HU; p &lt; 0.001). &lt;sup>18&lt;/sup>F-NaF TBR and SUVmax were correlated with PCAT density (r = 0.63 and r = 0.68, respectively; all p &lt; 0.001). On adjusted multiple regression analysis, increased lesion PCAT density and LAP volume were associated with &lt;sup>18&lt;/sup>F-NaF TBR (β = 0.25; 95% confidence interval: 0.17 to 0.34; p &lt; 0.001 for PCAT, and β = 0.07; 95% confidence interval: 0.03 to 0.11; p = 0.002 for LAP).&lt;h4>Conclusions&lt;/h4>In patients with HRP features on coronary CTA, increased density of PCAT was associated with focal &lt;sup>18&lt;/sup>F-NaF PET uptake. Simultaneous assessment of these imaging biomarkers by &lt;sup>18&lt;/sup>F-NaF PET and CTA might refine cardiovascular risk prediction in stable patients with HRP features.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Oct</publication><modification>2024-11-19T23:01:26.59Z</modification><creation>2020-10-08T07:16:36Z</creation></dates><accession>S-EPMC6689460</accession><cross_references><pubmed>30772226</pubmed><doi>10.1016/j.jcmg.2018.11.032</doi></cross_references></HashMap>